| 2025-07-08 |
MAEU253901495 |
GLENMARK PHARMACEUTICALS LTD |
6595.8 kg |
612600
|
40 PACKAGES 1722 CARTONS PHA RMACEUTICALS AS UNDER ONDANSE TRON ODT 4MG 30UD NDC CODE:68 462015713 FDA PRODUCT CODE N O,:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-1 52 THERAPEUTICE USE:-ANTI -E METIC MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 |
| 2025-07-08 |
MAEU254068350 |
GLENMARK PHARMACEUTICALS LTD |
10797.04 kg |
300490
|
45 PACKAGES 3139 CARTONS PHA RMACEUTICALS AS UNDER MUPIR OCIN OINT 2% 22GM NDC CODE:68 462018022 FDA PRODUCT CODE NO .: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-4 80 THERAPEUTICE USE: - ANTI- BACTERIAL OXCARBAZEPINE TAB 300MG 100 NDC CODE:68462 |
| 2025-07-01 |
MAEU254423349 |
MANKIND PHARMA LTD |
1028.31 kg |
650100
|
PART OF FCL 9 PACKAGES 391 CARTONS PHARMACEUTICALS AS U NDER VARENICLINE TABLETS 0. 5 MG & 1MG , (STARTING MONTH B OX) NDC NO. : 68462-895-04 F DA PRODUCT CODE : 65ZCA01 AND A NO. : 214255 H. T. S NO.: 3004.90.99 THERAPEUTIC USE : USE AS AN AID TO SMOKING |
| 2025-07-01 |
MAEU253901508 |
GLENMARK PHARMACEUTICALS LTD |
10115.73 kg |
300490
|
49 PACKAGES 1875 CARTONS PHA RMACEUTICALS AS UNDER ZONIS AMIDE CAP 100MG 100 NDC CODE: 68462013001 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO. : 3004.49.00.20 ANDA NO.:-77 -651 THERAPEUTICE USE:-ANTIS EIZURE DRUG ROPINIROLE TAB 1MG 100 NDC CODE:68462025 |
| 2025-07-01 |
MAEU253901497 |
GLENMARK PHARMACEUTICALS LTD |
11139.96 kg |
300490
|
45 PACKAGES 2069 CARTONS PHA RMACEUTICALS AS UNDER LIDOC AINE OINT JAR 5% 50GM NDC COD E:68462041827 FDA PRODUCT COD E NO.:60 Q C J 07 H. T. S NO .: 3004.49.00.50 ANDA NO.:20 6498 THERAPEUTICE USE: -USED TO TEMPORARILY RELIEVE PAIN AND ITCHING ASSOCIATED |
| 2025-07-01 |
MAEU254068352 |
GLENMARK PHARMACEUTICALS LTD |
4354.56 kg |
652500
|
PART OF FCL 30 PACKAGES 14 53 CARTONS PHARMACEUTICALS AS UNDER NORETH ACE/EE TAB 1/ 0.02MG 63 NDC CODE:6846201328 1 FDA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60. 00.00 ANDA NO.:206969 THERAP EUTICE USE: - SECONDARY AMEN ORRHEA,ENDOMETRIOS IS AND |
| 2025-07-01 |
MAEU254068351 |
GLENMARK PHARMACEUTICALS LTD |
8529.49 kg |
300490
|
45 PACKAGES 1680CARTONS PHAR MACEUTICALS AS UNDER OMEPRA ZOLE DR CAP 40MG 1000 NDC COD E:68462039710 FDA PRODUCT COD E NO.:62KCF10 HTS NO.3004.90 .9255 ANDA NO.:91672 THERAPE UTICE USE: -TREATMENT OF TREA T GASTROESOPHAGEAL REFLUX DI SEASE ZONISAMIDE CAP |
| 2025-07-01 |
MAEU254068353 |
GLENMARK PHARMACEUTICALS LTD |
10697.25 kg |
300490
|
47 PACKAGES 2175 CARTONS PHA RMACEUTICALS AS UNDER OLMES ARTAN MEDOX TAB 40MG 30 NDC C ODE:68462043830 FDA PRODUCT C ODE NO.: 62CCA68 H. T. S NO. : 3004.90.9220 ANDA NO.: 203 281 THERAPEUTICE USE: - -TRE ATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYP |
| 2025-06-23 |
MAEU253546362 |
GLENMARK PHARMACEUTICALS LTD |
4421.24 kg |
611600
|
PART OF FCL 15 PACKAGES 14 25 CARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 40M G 500 NDC CODE:68462026405 6 1 J C A 16 3004.49.00.10 791 72 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DIS EASE ROSUVASTATIN TAB 40MG 30 NDC CODE:68462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLEST EROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULA R DISEASE COMMERCIAL & CUST OM INVOICE NO. F22652000751 D T. 15.05.2025 S/BILL NO: 1863 197 DT 15-MAY-2025 GROSS WT. 4,421.489 KGS NET WT.3754.315 KGS 15 DATA LOGGERS HUMI DITY:65% SET TEMPERATURE : +1 8 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES N OTIFY PARTY:2 GLENMARK SPECIA LTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2 000 SWITZERLAND |
| 2025-06-23 |
MAEU254051397 |
GLENMARK PHARMACEUTICALS LTD |
4904.78 kg |
300490
|
28 PACKAGES 1449 CARTONS PHA RMACEUTICALS AS UNDER HEATH ER TAB 0.35MG 84 NDC CODE:684 62030329 FDA PRODUCT CODE NO. : 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.:90-454 THERAPEUTICE USE: PREVENTIO N OF PREGNANCY. IMIQUIMOD C REAM 5% 0.25GM 24 NDC CODE:68 462053670 FDA PRODUCT CODE NO .: 62 V C J 29 H. T. S NO.: 3004.49.00.50 ANDA NO.:20199 4 THERAPEUTICE USE: - INDICA TED FOR ACTINIC KERATOSES AND EXTERNAL GENITAL AND PERIAN AL WARTS GABAPENTIN TAB 600 MG 100 NDC CODE:68462012601 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 AND A NO.:-77-662 THERAPEUTICE U SE:-ANTICONVULSANT GABAPENT IN TAB 600MG 500 NDC CODE:684 62012605 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90 .9236 ANDA NO.:-77-662 THERA PEUTICE USE:-ANTICONVULSANT COMMERCIAL & CUSTOM INVOICE NO. F22652000758 DT. 15.05.20 25 F22652000750 DT. 14.05.202 5 F22652000760 DT. 15.05.2025 S/BILL NO: 1861722 DT 15-MAY -2025 S/BILL NO: 1861733 DT 1 5-MAY-2025 S/BILL NO: 1866240 DT 15-MAY-2025 GROSS WT. 4,9 04.970 KGS NET WT.3783.150 KG S 02 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
| 2025-06-23 |
MAEU253901515 |
GLENMARK PHARMACEUTICALS LTD |
8706.4 kg |
300490
|
40 PACKAGES 2612 CARTONS PHA RMACEUTICALS AS UNDER CLIND AMYCIN HCL CAP 300MG 100 NDC CODE:68462014401 FDA PRODUCT CODE NO.:56 J C E 20 H. T. S NO.: 2941.90.5000 ANDA NO.: 216957 THERAPEUTICE USE: :#T REATMENT OF NUMEROUS INFECTIO NS, INCLUDING BUT NOT LIMITE D TO SEPTICEMIA,INTRAABDOMINA L INFECTIONS, LOWER RESPIRAT ORY INFECTIONS, GYNECOLOGICAL INFECTIONS, BONE AND JOINT INFECTIONS, AND SKIN AND SKIN STRUCTURE INFECTIONS METF ORMIN HCL ER TAB (Z) 500MG 100 NDC CODE:68462052001 FDA PR ODUCT CODE NO.: 61 P C A 55 H. T. S NO.: 3004.90.92.40 A NDA NO.:212969 THERAPEUTICE U SE: THE MANAGEMENT OF TYPE 2 DIABETES GABAPENTIN TAB 60 0MG 500 NDC CODE:68462012605 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 AN DA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT PIMECRO LIMUS CREAM 1% 100GM NDC CODE :68462060994 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO .: 3004.90.92.45 ANDA NO.: 2 11769 THERAPEUTICE USE: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NON- IMMUNOCOMPROMISED A DULT AND CHILDREN 2 YEARS OF AGE TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THER APEUTIC USE : TO PREVENT REJE CTION OF A KIDNEY,HEART, OR L IVER TRANSPLANT TACROLIMUS CAP 5MG 100 NDC CODE:6846206 8701 HTS NO: 3004.90.92.15 F DA CODE : 64 T C E 08 ANDA NO .206662 THERAPEUTICE USE: TO PREVENT REJECTION OF A KIDNE Y, HEART, OR LIVER TRANSPLANT TACROLIMUS OINTMENT 0.03% 30GM NDC CODE:68462088135 FD A PRODUCT CODE NO.:64 T C J 0 8 H. T. S NO.: 3004.49.0050 ANDA NO.:210393 THERAPEUTICE USE: TOPICAL IMMUNOSUPPRESS IVE AGENT TACROLIMUS OINTM ENT 0.03% 60GM NDC CODE:68462 088165 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 300 4.49.0050 ANDA NO.:210393 TH ERAPEUTICE USE: TOPICAL IMMU NOSUPPRESSIVE AGENT PIMECR OLIMUS CREAM 1% 60GM NDC CODE :68462060965 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO .: 3004.90.92.45 ANDA NO.: 2 11769 THERAPEUTICE USE: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NON- IMMUNOCOMPROMISED A DULT AND CHILDREN 2 YEARS OF AGE COMMERCIAL & CUSTOM I NVOICE NO. F22687000293 DT. 1 9.05.2025 F22687000296 DT. 19 .05.2025 F22687000297 DT. 19. 05.2025 F22687000301 DT. 19.0 5.2025 S/BILL NO:1961056 DT:1 9-MAY-25 S/BILL NO:1961053 DT :19-MAY-25 S/BILL NO:1961042 DT:19-MAY-25 S/BILL NO:196104 4 DT:19-MAY-25 GROSS WT. 8,70 6.626 KGS NET WT.4586.718 KGS 02 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA |
| 2025-06-23 |
MAEU254208262 |
GLENMARK PHARMACEUTICALS LTD |
3648.76 kg |
611600
|
PART OF FCL 14 PACKAGES 16 37CARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 40MG 500 NDC CODE:68462026405 61 J C A 16 3004.49.00.10 7917 2 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND T O PREVENT CARDIOVASCULAR DISE ASE ROSUVASTATIN TAB 40MG 3 0 NDC CODE:68462026430 FDA P RODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 A NDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTE ROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 4 0MG 30 NDC CODE:68462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00. 10 ANDA NO.: 079172 THERAPEU TICE USE: - TO TREAT HIGH CHO LESTEROL AND RELATED CONDITIO NS, AND TO PREVENT CARDIOVAS CULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO. F226520007 68 DT. 16.05.2025 F2265200078 1 DT. 16.05.2025 S/BILL NO: 1 919789 DT 17-MAY-2025 S/BILL NO: 1919807 DT 17-MAY-2025 GR OSS WT. 3,649.116 KGS NET WT. 2955.054 KGS 14 DATA LOGGERS SET TEMPERATURE : +18 DEGR EES NOTIFY PARTY:2 GLENMAR K SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCH ATEL - 2000 SWITZERLAND |
| 2025-06-23 |
MAEU254178145 |
MANKIND PHARMA LTD |
2661.27 kg |
650100
|
PART OF FCL 16 PACKAGES 18 17 CARTONS PHARMACEUTICALS AS UNDER VARENICLINE TABLETS 1 MG, 56CT NDC NO. : 68462-89 4-56 FDA PRODUCT CODE : 65ZCA 01 ANDA NO. : 214255 H. T. S NO.: 3004.90.99 THERAPEUTIC USE : USE AS AN AID TO SMOK ING CESSATION TREATMENT VAR ENICLINE TABLETS 1 MG, 56CT N DC NO. : 68462-894-56 FDA PRO DUCT CODE : 65ZCA01 ANDA NO. : 214255 H. T. S NO.: 3004.9 0.99 THERAPEUTIC USE : USE AS AN AID TO SMOKING CESSATION TREATMENT VARENICLINE TABL ETS 1 MG, 56CT NDC NO. : 6846 2-894-56 FDA PRODUCT CODE : 6 5ZCA01 ANDA NO. : 214255 H. T. S NO.: 3004.90.99 THERAPE UTIC USE : USE AS AN AID TO SMOKING CESSATION TREATMENT VARENICLINE TABLETS 1 MG, 56C T NDC NO. : 68462-894-56 FDA PRODUCT CODE : 65ZCA01 ANDA NO. : 214255 H. T. S NO.: 30 04.90.99 THERAPEUTIC USE : USE AS AN AID TO SMOKING CESSA TION TREATMENT COMMERCIAL & CUSTOM INVOICE NO. 832436426 DTD 15.05.2025 S/BILL NO: 19 52773 DT: 19/05/2025 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA |
| 2025-06-23 |
MAEU254068114 |
GLENMARK PHARMACEUTICALS LTD |
2094.27 kg |
653900
|
14 PACKAGES 700 CARTONS PHAR MACEUTICALS AS UNDER DROSPI RENONE/EE TAB 3/0.03MG 84 NDC CODE:68462073329 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA N O.: 204848 THERAPEUTICE USE: - CONTRACEPTION TO PREVENT P REGNANCY COMMERCIAL & CUSTO M INVOICE NO. F22652000798 DT . 17.05.2025 S/BILL NO: 19478 80 DT:19/05/2025 GROSS WT. 2, 094.400 KGS NET WT.1,512.00 K GS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA |
| 2025-06-23 |
MAEU254244878 |
GLAND PHARMA LIMITED |
2461.69 kg |
640921
|
PART OF FCL 5 PACKAGES 457 C ARTONS PHARMACEUTICALS AS UND ER BUMETANIDE INJECTION USP 2.5MG/10ML (0.25MG/ML) NDC N O. : 68462-470-54 FDA PRODUCT CODE : 64BCK09 ANDA NO. : 21 6434 H. T. S NO.: 3004.90.92 59 COMMERCIAL & CUSTOM INVO ICE NO. M72617000050 DT 06.05 .2025 S/BILL NO: 1741967 DT: 13/05/2025 GROSS WT. 2,461.83 0 KGS NET WT.2118.652 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC ., USA 301, ISLAND RD NEW JE RSEY MAHWAH USA- 07430 LABE LER CODE : 68462: |
| 2025-06-17 |
MAEU253546357 |
GLENMARK PHARMACEUTICALS LTD |
10875.97 kg |
300490
|
44 PACKAGES 2194 CARTONS PHA RMACEUTICALS AS UNDER NAPRO XEN TAB 500MG 500 NDC CODE:68 462019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-2 50 THERAPEUTICE USE:-ANTI-IN FLAMMATORY, ANALGESIC LAMO TRIGINE TAB CD 5MG 100 NDC CO DE:68462022801 FDA PRODUCT CO DE NO.:- 61 M C A 38 H. T. S NO.: 3004.90.92.30 ANDA NO. :-79 # 099 THERAPEUTICE USE:- ANTICONVULSANT OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:68 462039610 FDA PRODUCT CODE N O.:62KCF10 HTS NO.3004.90.925 5 ANDA NO.:91672 THERAPEUTIC E USE: -TREATMENT OF TREAT G ASTROESOPHAGEAL REFLUX DISEAS E OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PR ODUCT CODE NO.:62KCF10 HTS N O.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMEN T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE ATOVAQUONE-P ROG TAB 250/100MG 100 NDC COD E:68462040401 FDA PRODUCT COD E NO.: 62 L D A 44 H. T. S N O.: 3004.90.92.90 ANDA NO.: 91-211 THERAPEUTICE USE: - AN TI MALARIAL ROSUVASTATIN T AB 5MG 1000 NDC CODE:68462026 110 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004. 49.00.10 ANDA NO.: 79172 THE RAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDI TIONS, AND TO PREVENT CARDIOV ASCULAR DISEASE. COMMERCIA L & CUSTOM INVOICE NO. F22652 000711 DT. 12.05.2025 F226520 00712 DT. 12.05.2025 F2265200 0713 DT. 12.05.2025 F22652000 714 DT. 12.05.2025 GROSS WT. 10,876.280 KGS NET WT.9210.49 KGS 03 DATA LOGGERS HUMI DITY:65% SET TEMPERATURE : +1 8 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES S/BILL NO: 1749387 DT 13-MAY- 2025 S/BILL NO: 1749392 DT 13 -MAY-2025 S/BILL NO: 1749384 DT 13-MAY-2025 S/BILL NO: 174 9391 DT 13-MAY-2025 NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA NOTIFY PARTY:3 GLE NMARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE DU PORT 2 N EUCHATEL - 2000 SWITZERLAND |
| 2025-06-17 |
MAEU253805863 |
GLENMARK PHARMACEUTICALS LTD |
1095.44 kg |
620300
|
PART OF FCL 4 PACKAGES 8 8 CARTONS PHARMACEUTICALS AS UNDER AZELAIC ACID GEL 15% 50GM NDC CODE:68462062652 FD A PRODUCT CODE NO.: 62 S C J 03 H. T. S NO.: 3004.49.00.5 0 ANDA NO.: 204637 INDICATED FOR TOPICAL TREATMENT OF THE INFLAMMATORY PAPULES AND PU STULES OF MILD TO MODERATE RO SACEA COMMERCIAL & CUSTOM I NVOICE NO. F22652000661 DT. 0 8.05.2025 S/BILL NO: 1667119 DT 09-MAY-2025 GROSS WT. 1,09 5.600 KGS NET WT.906.400 KGS 06 DATA LOGGERS SET TEMPE RATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S .A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
| 2025-06-17 |
MAEU253546366 |
GLENMARK PHARMACEUTICALS LTD |
11321.4 kg |
300490
|
45 PACKAGES 4119 CARTONS PHA RMACEUTICALS AS UNDER TELMI SARTAN TAB 40MG 30 NDC CODE:6 8462020030 FDA PRODUCT CODE N O.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO.:0900 32 THERAPEUTICE USE: INDICAT ED FOR THE TREATMENT OF HYPE RTENSION, TO LOWER BLOOD PRES SURE ROPINIROLE TAB 0.25MG 100 NDC CODE:68462025301 FDA PRODUCT CODE NO.:-62 J C A 1 7 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUT ICE USE:-TREATMENT OF PARKIN SONISM ROPINIROLE TAB 0.5MG 100 NDC CODE:68462025401 FD A PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:- 90-135 THERAPEU TICE USE:-TREATMENT OF PARKI NSONISM OMEPRAZOLE DR CAP 4 0MG 90 NDC CODE:68462039790 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO. :91672 THERAPEUTICE USE: -TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE LITHIU M CARB CAP 600MG 100 NDC CODE :68462022201 FDA PRODUCT CODE NO.:-61 N C E 37 H. T. S NO .: 3004.49.00.20 ANDA NO.:- 79 -139 THERAPEUTICE USE:-AN TIMANIC AGENT NAPROXEN TAB 500MG 100 NDC CODE:6846201900 1 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90 .92.40 ANDA NO.:-78-250 THER APEUTICE USE:-ANTI-INFLAMMATO RY, ANALGESIC COMMERCIAL & CUSTOM INVOICE NO. F22652000 695 DT. 10.05.2025 F226520006 96 DT. 10.05.2025 F2265200069 7 DT. 10.05.2025 S/BILL NO: 1 708116 DT 12-MAY-2025 S/BILL NO: 1711169 DT 12-MAY-2025 S/ BILL NO: 1713005 DT 12-MAY-202 5 GROSS WT. 11,321.380 KG NET WT.9218.400 KGS 02 DATA L OGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA |
| 2025-06-17 |
MAEU253805224 |
GLENMARK PHARMACEUTICALS LTD |
2222.64 kg |
611600
|
PART OF FCL 10 PACKAGES 12 90 CARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 5MG 90 NDC CODE:68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTIC E USE: - TO TREAT HIGH CHOLES TEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCUL AR DISEASE COMMERCIAL & CUS TOM INVOICE NO. F22652000653 DT. 08.05.2025 S/BILL NO: 164 1879 DT 08-MAY-2025 GROSS WT. 2,222.928 KGS NET WT.1665.64 8 KGS 10 DATA LOGGERS SET T EMPERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLA CE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
| 2025-06-17 |
MAEU253741884 |
GLENMARK PHARMACEUTICALS LTD |
7527.95 kg |
300490
|
42 PACKAGES 1722 CARTONS PHA RMACEUTICALS AS UNDER OMEPR AZOLE DR CAP 40MG 1000 NDC CO DE:68462039710 FDA PRODUCT CO DE NO.:62KCF10 HTS NO.3004.9 0.9255 ANDA NO.:91672 THERAP EUTICE USE: -TREATMENT OF TRE AT GASTROESOPHAGEAL REFLUX D ISEASE ZONISAMIDE CAP 50MG 100 NDC CODE:68462012901 FDA PRODUCT CODE NO.:-61 M C E 4 4 H. T. S NO.: 3004.49.00.20 ANDA NO.:-77-651 THERAPEUTI CE USE:-ANTISEIZURE DRUG Z ONISAMIDE CAP 50MG 100 NDC CO DE:68462012901 FDA PRODUCT CO DE NO.:-61 M C E 44 H. T. S NO.: 3004.49.00.20 ANDA NO.: -77-651 THERAPEUTICE USE:-AN TISEIZURE DRUG OMEPRAZOLE D R CAP 20MG 1000 NDC CODE:6846 2039610 FDA PRODUCT CODE NO. :62KCF10 HTS NO.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GAS TROESOPHAGEAL REFLUX DISEASE AZELAIC ACID GEL 15% 50GM NDC CODE:68462062652 FDA PROD UCT CODE NO.: 62 S C J 03 H. T. S NO.: 3004.49.00.50 AND A NO.: 204637 INDICATED FOR T OPICAL TREATMENT OF THE INFL AMMATORY PAPULES AND PUSTULES OF MILD TO MODERATE ROSACEA HEATHER TAB 0.35MG 84 NDC CODE:68462030329 FDA PRODUCT CODE NO.: 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO .:90-454 THERAPEUTICE USE: P REVENTION OF PREGNANCY. COM MERCIAL & CUSTOM INVOICE NO. F22652000721 DT. 13.05.2025 F 22652000723 DT. 13.05.2025 F2 2652000726 DT. 13.05.2025 F22 652000720 DT. 13.05.2025 F226 52000740 DT. 14.05.2025 GROSS WT. 7,528.060 KGS NET WT.594 7.95 KGS 07 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RAN GE : +15 DEGREES TO +25 DEGREE S S/BILL NO: 1763694 DT 13- MAY-2025 S/BILL NO: 1764792 D T 13-MAY-2025 S/BILL NO: 1765 143 DT 13-MAY-2025 S/BILL NO: 1765497 DT 13-MAY-2025 S/BIL L NO: 1780468 DT 14-MAY-2025 NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA NOTIFY PARTY :3 GLENMARK SPECIALTY S.A. S WITZERLAND (GSSA) PLACE DU PO RT 2 NEUCHATEL - 2000 SWITZE RLAND |
| 2025-06-17 |
MAEU253741782 |
GLENMARK PHARMACEUTICALS LTD |
7529.31 kg |
300490
|
44 PACKAGES 2923 CARTONS PHA RMACEUTICALS AS UNDER ONDAN SETRON ODT 4MG 30UD NDC CODE: 68462015713 FDA PRODUCT CODE NO,:-61 T C A 26 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -152 THERAPEUTICE USE:-ANTI -EMETIC OMEPRAZOLE DR CAP 2 0MG 1000 NDC CODE:68462039610 FDA PRODUCT CODE NO.:62KCF1 0 HTS NO.3004.90.9255 ANDA N O.:91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOP HAGEAL REFLUX DISEASE ROSU VASTATIN TAB 40MG 30 NDC CODE :68462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE N O. F22652000725 DT. 13.05.202 5 F22652000733 DT. 13.05.2025 S/BILL NO: 1765494 DT 13-MAY -2025 S/BILL NO: 1765436 DT 1 3-MAY-2025 GROSS WT. 7,529.43 0 KGS NET WT.5612.970 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR EES TO +25 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK SPE CIALTY S.A. SWITZERLAND (GSSA ) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
| 2025-06-17 |
MAEU253375525 |
GLENMARK PHARMACEUTICALS LTD |
8551.72 kg |
652500
|
46 PACKAGES 3146 CARTONS PHA RMACEUTICALS AS UNDER HAILE Y 24 FE TAB 1MG/20MCG-75MG 84 NDC CODE:68462073129 FDA PRO DUCT CODE NO.: 65 J D A 25 H . T. S NO.: 3006.60.00.00 AN DA NO.: 204847 THERAPEUTICE U SE: - CONTRACEPTION TO PREVEN T PREGNANCY NORETHINDRONE ACE TAB 5MG 50 NDC CODE:68462 030450 FDA PRODUCT CODE NO.6 5 J C A 25 H. T. S NO.: 3004 .39.00.50 ANDA NO.:-91-090 T HERAPEUTICE USE:- SECONDARY AMENORRHEA,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING ATOMOXETINE CAP 18MG 30 NDC CODE:68462026630 FDA PRODUCT CODE NO.: 64 UCA 99 H. T. S NO.: 3004.90.92.90 ANDA NO.: 079019 THERAPEUTICE USE : - ATOMOXETINE IS USED TO TREAT ATTENTION-DEFICIT HYPERACTIV ITY DISORDER (ADHD) AS PART O F A TOTAL TREATMENT PLAN, INC LUDING PSYCHOLOGICAL, SOCIAL, AND OTHER TREATMENTS RILU ZOLE TAB 50MG 60 NDC CODE:684 62038160 FDA PRODUCT CODE NO. : 62 J C A 16 H. T. S NO.: 3004.90.92.30 ANDA NO.: 91394 THERAPEUTICE USE: - A-PARKI NSONIAN/ HUMAN - RX/SINGLE IN GREDIENT / PROMPT RELEASE TAB LETS / RILUZOLE (ANTI-PARKIN SONIAN) AZELAIC ACID GEL 15 % 50GM NDC CODE:68462062652 FDA PRODUCT CODE NO.: 62 S C J 03 H. T. S NO.: 3004.49.00 .50 ANDA NO.: 204637 INDICAT ED FOR TOPICAL TREATMENT OF T HE INFLAMMATORY PAPULES AND PUSTULES OF MILD TO MODERATE ROSACEA ROSUVASTATIN TAB 5M G 90 NDC CODE:68462026190 FD A PRODUCT CODE NO.:61 J C A 1 6 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTI CE USE: - TO TREAT HIGH CHOLE STEROL AND RELATED CONDITIONS , AND TO PREVENT CARDIOVASCU LAR DISEASE COMMERCIAL & CU STOM INVOICE NO. F22652000639 DT. 07.05.2025 F22652000640 DT. 07.05.2025 F22652000647 D T. 07.05.2025 F22652000645 DT . 07.05.2025 F22652000646 DT. 07.05.2025 S/BILL NO:1621466 DT 08-MAY-2025 S/BILL NO:162 9262 DT 08-MAY-2025 S/BILL NO :1628948 DT 08-MAY-2025 S/BIL L NO:1628949 DT 08-MAY-2025 S /BILL NO:1628952 DT 08-MAY-202 5 GROSS WT. 8,551.953 KGS NE T WT.6569.451 KGS 16 DATA LOGGERS HUMIDITY:65% SET TEM PERATURE : +18 DEGREES TEMPER ATURE RANGE : +15 DEGREES TO + 25 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S .A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND |
| 2025-06-17 |
MAEU253375523 |
GLENMARK PHARMACEUTICALS LTD |
4487.92 kg |
652500
|
30 PACKAGES 1500 CARTONS PHA RMACEUTICALS AS UNDER NORET H ACE/EE TAB 1/0.02MG 63 NDC CODE:68462013281 FDA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00.00 ANDA NO. :206969 THERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOMETR IOS IS AND ABNORMAL UTERINE BLEEDING COMMERCIAL & CUSTO M INVOICE NO. F22652000694 DT . 10.05.2025 S/BILL NO: 17081 41 DT 12-MAY-2025 GROSS WT. 4 ,488.000 KGS NET WT.3240.000 KGS 02 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : + 15 DEGREES TO +25 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA |
| 2025-06-17 |
MAEU253533924 |
GLENMARK PHARMACEUTICALS LTD |
10138.41 kg |
300490
|
44 PACKAGES 3454 CARTONS PHA RMACEUTICALS AS UNDER OMEPR AZOLE DR CAP 20MG 90 NDC CODE :68462039690 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90. 9255 ANDA NO.:91672 THERAPEU TICE USE: -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DIS EASE TELMISARTAN TAB 40MG 9 0 NDC CODE:68462020090 FDA P RODUCT CODE NO :62 O C A 09 HTS NO : 3004.90.92.20 ANDA N O.90032 THERAPEUTICE USE:-IN DICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE ROPINIROLE TAB 0. 25MG 100 NDC CODE:68462025301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90. 92.40 ANDA NO.:- 90-135 THER APEUTICE USE:-TREATMENT OF P ARKINSONISM ROPINIROLE TAB 0.5MG 100 NDC CODE:6846202540 1 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90 .92.40 ANDA NO.:- 90-135 THE RAPEUTICE USE:-TREATMENT OF PARKINSONISM OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039 790 FDA PRODUCT CODE NO.:62K CF10 HTS NO.3004.90.9255 AND A NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GASTROE SOPHAGEAL REFLUX DISEASE O LMESARTAN MEDOX TAB 20MG 30 N DC CODE:68462043730 FDA PRODU CT CODE NO.: 62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO.: 203281 THERAPEUTICE USE: - -TREATMENT OF HYPERTENSION, A LONE OR WITH OTHER ANTIHYPER TENSIVE AGENTS, TO LOWER BLOO D PRESSURE COMMERCIAL & CUS TOM INVOICE NO. F22652000683 DT. 09.05.2025 S/BILL NO: 168 5034 DT 10-MAY-2025 GROSS WT. 10,138.488 KGS NET WT.8181.7 30 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
| 2025-06-17 |
MAEU253546360 |
GLENMARK PHARMACEUTICALS LTD |
8920.5 kg |
300490
|
PART OF FCL 41 PACKAGES 32 11 CARTONS PHARMACEUTICALS AS UNDER ATOMOXETINE CAP 80MG 30 NDC CODE:68462027030 FDA PRODUCT CODE NO.: 64 UCA 99 H. T. S NO.:3004.90.92.90 A NDA NO.: 079019 THERAPEUTICE USE: - ATOMOXETINE IS USED TO TREAT ATTENTION-DEFICIT HYP ERACTIVITY DISORDER (ADHD) AS PART OF A TOTAL TREATMENT PL AN, INCLUDING PSYCHOLOGICAL, SOCIAL, AND OTHER TREATMENTS FLUCONAZOLE TAB 200MG 30 N DC CODE:68462010430 FDA PRODU CT CODE NO : 61 W C A 45 H. T. S NO.: 3004.90.92.45 ANDA NO.:-77 - 253 THERAPEUTICE USE:-ANTIFUNGAL FLUCONAZOLE TAB 200MG 30 NDC CODE:684620 10430 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO.: 300 4.90.92.45 ANDA NO.:-77 - 253 THERAPEUTICE USE:-ANTIFUNGA L LITHIUM CARB CAP 600MG 10 0 NDC CODE:68462022201 FDA P RODUCT CODE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 79 -139 THERAPEUTI CE USE:-ANTIMANIC AGENT OM EPRAZOLE DR CAP 40MG 90 NDC C ODE:68462039790 FDA PRODUCT C ODE NO.:62KCF10 HTS NO.3004. 90.9255 ANDA NO.:91672 THERA PEUTICE USE: -TREATMENT OF TR EAT GASTROESOPHAGEAL REFLUX DISEASE ONDANSETRON ODT 8MG 30UD NDC CODE:68462015813 F DA PRODUCT CODE.:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-152 THERAPEUTIC E USE:-ANTI -EMETIC COMMER CIAL & CUSTOM INVOICE NO. F22 652000660 DT. 08.05.2025 F226 52000662 DT. 08.05.2025 F2265 2000663 DT. 08.05.2025 F22652 000671 DT. 09.05.2025 S/BILL NO: 1660363 DT 09-MAY-2025 S/ BILL NO: 1663593 DT 09-MAY-202 5 S/BILL NO: 1675644 DT 09-MA Y-2025 S/BILL NO: 1675642 DT 09-MAY-2025 GROSS WT. 8,920 .777 KGS NET WT.7071.061 KGS 02 DATA LOGGERS SET TEMPER ATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
| 2025-06-10 |
MAEU253325264 |
GLENMARK PHARMACEUTICALS LTD |
6048.76 kg |
300490
|
26 PACKAGES 765 CARTONS PHAR MACEUTICALS AS UNDER OMEPRA ZOLE DR CAP 40MG 1000 NDC COD E:68462039710 FDA PRODUCT COD E NO.:62KCF10 HTS NO.3004.90 .9255 ANDA NO.:91672 THERAPE UTICE USE: -TREATMENT OF TREA T GASTROESOPHAGEAL REFLUX DI SEASE GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODUCT CODE:NO : 61 N C A 6 9 HTS NO.3004.90.9236 ANDA N O.:-77-662 THERAPEUTICE USE: -ANTICONVULSANT MUPIROCIN O INT 2% 22GM NDC CODE:68462018 022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004. 90.92.45 ANDA NO.: 90-480 TH ERAPEUTICE USE: - ANTI-BACTER IAL COMMERCIAL & CUSTOM INV OICE NO. F22652000491 DT. 30. 04.2025 F22652000534 DT. 30.0 4.2025 F22652000561 DT. 30.04 .2025 S/BILL NO: 1509298 DT 0 3-MAY-2025 S/BILL NO: 1509301 DT 03-MAY-2025 S/BILL NO: 15 09304 DT 03-MAY-2025 GROSS WT . 6,049.046 KGS NET WT.5167.0 57 KGS 02 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA |
| 2025-06-10 |
MAEU253375357 |
GLENMARK PHARMACEUTICALS LTD |
7709.39 kg |
300490
|
44 PACKAGES 2465 CARTONS PHA RMACEUTICALS AS UNDER METRO NIDAZOLE VAG GEL 0.75% 70GM N DC CODE:68462018449 FDA PRODU CT CODE NO.: 62 L C J 40 H. T. S NO.: 3004.90.92.45 ANDA NO.: 215794 THERAPEUTICE USE : METRONIDAZOLE VAGINAL GEL IS INDICATED IN THE TREATMENT OF BACTERIAL VAGINOSIS (FORM ERLY REFERRED TO AS HAEMOPHI LUS VAGINITIS, GARDNERELLA V AGINITIS, NONSPECIFIC VAGINIT IS, CORYNEBACTERIUM VAGINITI S, OR ANAEROBIC VAGINOSIS). ONDANSETRON ODT 4MG 30UD ND C CODE:68462015713 FDA PRODUC T CODE NO,:-61 T C A 26 H. T . S NO.: 3004.90.92.40 ANDA NO.:-78-152 THERAPEUTICE USE: -ANTI -EMETIC OMEPRAZOLE D R CAP 20MG 1000 NDC CODE:6846 2039610 FDA PRODUCT CODE NO. :62KCF10 HTS NO.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GAS TROESOPHAGEAL REFLUX DISEASE AZELAIC ACID GEL 15% 50GM NDC CODE:68462062652 FDA PROD UCT CODE NO.: 62 S C J 03 H. T. S NO.: 3004.49.00.50 AND A NO.: 204637 INDICATED FOR T OPICAL TREATMENT OF THE INFL AMMATORY PAPULES AND PUSTULES OF MILD TO MODERATE ROSACEA COMMERCIAL & CUSTOM INVOICE NO. F22652000615 DT. 05.05.2 025 F22652000460 DT. 29.04.20 25 F22652000616 DT. 05.05.202 5 F22652000614 DT. 05.05.2025 S/BILL NO:1564395 DT 06-MAY- 2025 S/BILL NO:1563644 DT 06- MAY-2025 S/BILL NO:1563210 DT 06-MAY-2025 S/BILL NO:156320 8 DT 06-MAY-2025 GROSS WT. 7, 709.278 KGS NET WT.5740.835 K GS 03 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : + 15 DEGREES TO +25 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA NOTIFY PARTY:3 GLENM ARK SPECIALTY S.A. SWITZERLAN D (GSSA) PLACE DU PORT 2 NEU CHATEL - 2000 SWITZERLAND |
| 2025-06-10 |
MAEU253325267 |
GLENMARK PHARMACEUTICALS LTD |
7661.3 kg |
300490
|
41 PACKAGES 2795 CARTONS PHARMACEUTICALS AS UNDER CLINDAMYCIN HCL CAP 150MG 100 NDC CODE:68462014301 FDA PRODUCT CODE NO.:56 J C E 20 H. T. S NO.: 2941 .90.5000 ANDA NO.:216957 THERAPEUTICE USE: :#TREATM ENT OF NUMEROUS INFECTIONS, INCLUDING BUT NOT LIMIT ED TO SEPTICEMIA,INTRAABDOM INAL INFECTIONS, LOWER R ESPIRATORY INFECTIONS, GYNE COLOGICAL INFECTIONS, BONE AND JOINT INFECTIONS, AND SKIN AND SKIN STRUCTURE I NFECTIONS METFORMIN HC L ER TAB (Z) 1000MG 90 NDC CODE:68462052190 FDA PRODUC T CODE NO.: 61 P C A 55 H. T. S NO.: 3004.90.92.40 ANDA NO.:212969 THERAPEU TICE USE: THE MANAGEMENT OF TYPE 2 DIABETES IN DOMETHACIN ER CAP 75MG 100 NDC CODE:68462032501 FDA PR ODUCT CODE NO.: 62GCE42 H. T. S NO.: 3004.90.92.40 ANDA NO.: 203501 THERAPE UTICE USE: :#INDOMETHACIN I S USED TO RELIEVE PAIN, SWELLING,AND JOINT STIFFNES S CAUSED BY ARTHRITIS, GOUT , BURSITIS,AND TENDONITI S.AND TENDONITIS.IT IS ALSO USED TO RELIEVE PAIN FROM VARIOUS AS DECREASE SWEL LING ANDTHIS EFFECT HELPS T OANTI-INFLAMMATORY DRUGA NO NSTEROIDALTHIS MEDICATION I S KNOWNCONDITIONS. CLINDAMYCIN HCL CAP 150MG 500 NDC CODE:68462014305 FDA PRODUCT CODE NO.:56 J C E 20 H. T. S NO.: 2941.90. 5000 ANDA NO.:216957 THE RAPEUTICE USE: :#TREATMENT OF NUMEROUS INFECTIONS, INC LUDING BUT NOT LIMITED T O SEPTICEMIA,INTRAABDOMINAL INFECTIONS, LOWER RESPI RATORY INFECTIONS, GYNECOLO GICAL INFECTIONS, BONE AND JOINT INFECTIONS, AND SK IN AND SKIN STRUCTURE INFEC TIONS NEBIVOLOL TAB 10 MG 90 (AK) NDC CODE:4229108 7390 FDA PRODUCT CODE 62 C C A 99 HTS NO.3004.90.92 21 ANDA NO. 203821 THERA PEUTICE USE. ANTI-HYPERTENS IVE NEBIVOLOL TAB 20MG 90 (AK) NDC CODE:422910874 90 FDA PRODUCT CODE 62 C C A 99 HTS NO.3004.90.9221 ANDA NO. 203821 THERAPE UTICE USE. ANTI-HYPERTENSIV E TACROLIMUS OINT 0.1% 30GM NDC CODE:68462053435 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 2103 93 THERAPEUTICE USE: - T ACROLIMUS IS A TOPICAL IMMU NOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MO DERATE-TO-SEVERE ATOPIC DER MATITIS (ECZEMA). S IROLIMUS TAB 1MG 100 NDC CO DE:68462068301 FDA PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90.92.15 ANDA NO.: 208691 THERAPEUT ICE USE: TO PREVENT REJECTI ON OF KIDNEY TRANSPLANTS. TACROLIMUS CAP 0.5MG 10 0 NDC CODE:68462068501 F DA PRODUCT CODE NO.: 64 T C E 08 H. T. S NO.:3004.9 0.92.15 ANDA NO.: 206662 THERAPEUTICE USE: :#TO PRE VENT REJECTION OF A KIDNEY, TO PREVENT REJECTION OF A K IDNEY,LIVER TRANSPLANT CARVEDILOL TAB 12.5MG 500 NDC CODE:68462016405 FDA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 A NDA NO.78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST CARVEDI LOL TAB 12.5MG 500 NDC CODE :68462016405 FDA PRODUCT CO DE NO :62 O C A 22 HTS N O.3004.90.9221 ANDA NO.78-2 51 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGON IST TACROLIMUS OINT 0. 1% 100GM NDC CODE:684620534 94 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 2 10393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL I MMUNOSUPPRESSIVE OINTMENT U SED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49. 00.50 ANDA NO.: 210393 T HERAPEUTICE USE: - TACROLIM US IS A TOPICAL IMMUNOSUPPR ESSIVE OINTMENT USED FOR TH E TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIM US OINT 0.1% 30GM NDC CODE: 68462053435 FDA PRODUCT COD E NO.: 64 T C J 08 H. T. |
| 2025-06-10 |
MAEU253325261 |
GLENMARK PHARMACEUTICALS LTD |
7067.09 kg |
300490
|
33 PACKAGES 1009 CARTONS PHA RMACEUTICALS AS UNDER MUPIR OCIN OINT 2% 22GM NDC CODE:68 462018022 FDA PRODUCT CODE NO .: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-4 80 THERAPEUTICE USE: - ANTI- BACTERIAL METRONIDAZOLE VAG GEL 0.75% 70GM NDC CODE:6846 2018449 FDA PRODUCT CODE NO.: 62 L C J 40 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 215794 THERAPEUTICE USE: METRONIDA ZOLE VAGINAL GEL IS INDICATED IN THE TREATMENT OF BACTERIA L VAGINOSIS (FORMERLY REFERR ED TO AS HAEMOPHILUS VAGINIT IS, GARDNERELLA VAGINITIS, NO NSPECIFIC VAGINITIS, CORYNEB ACTERIUM VAGINITIS, OR ANAERO BIC VAGINOSIS). GABAPENTIN TAB 600MG 500 NDC CODE:68462 012605 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9 236 ANDA NO.:-77-662 THERAPE UTICE USE:-ANTICONVULSANT OMEPRAZOLE DR CAP 40MG 1000 N DC CODE:68462039710 FDA PRODU CT CODE NO.:62KCF10 HTS NO.3 004.90.9255 ANDA NO.:91672 T HERAPEUTICE USE: -TREATMENT O F TREAT GASTROESOPHAGEAL REFL UX DISEASE OMEPRAZOLE DR C AP 20MG 1000 NDC CODE:6846203 9610 FDA PRODUCT CODE NO.:62 KCF10 HTS NO.3004.90.9255 AN DA NO.:91672 THERAPEUTICE USE : -TREATMENT OF TREAT GASTRO ESOPHAGEAL REFLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO . F22652000540 DT. 30.04.2025 F22652000548 DT. 30.04.2025 F22652000464 DT. 29.04.2025 F22652000504 DT. 30.04.2025 S /BILL NO: 1480687 DT 02-MAY-20 25 S/BILL NO: 1480693 DT 02-M AY-2025 S/BILL NO: 1480691 DT 02-MAY-2025 S/BILL NO: 14806 94 DT 02-MAY-2025 GROSS WT. 7,067.110 KGS NET WT.6060.37 7 KGS 02 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : + 15 DEGREES TO +25 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA |
| 2025-06-10 |
MAEU253315296 |
GLENMARK PHARMACEUTICALS LTD |
2306.56 kg |
617200
|
15 PACKAGES 565 CARTONS PHAR MACEUTICALS AS UNDER SOLIFE NACIN SUCCINATE TAB 10MG 30 N DC CODE:68462038730 FDA PRODU CT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA N O.: 209239 INDICATED FOR THE TREATMENT OF OVERACTIVE BLAD DER WITH SYMPTOMS OF URGE URI NARY INCONTINENCE, URGENCY A ND URINARY FREQUENCY APREPI TANT CAP 80MG 2UOU NDC CODE:6 8462058458 FDA PRODUCT CODE N O.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO.:2077 77 THERAPEUTICE USE:APREPITA NT IS USED WITH OTHER MEDICAT IONS TO HELP PREVENT NAUSEA A ND VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOTHERAPY ). THIS MEDICATION IS ALSO US ED TO PREVENT NAUSEA AND VOM ITING AFTER SURGERY. A-EMETIC /NAUSEANT / HUMAN - RX/SINGLE INGREDIENT / DELAYED RELEAS E TABLETS / APREPITANT NIT ROGLYCERIN SUBLING TAB 0.4MG 1 00 NDC CODE:68462063901 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.: 206391 THERAPEUTICE USE: -MEDICATION USED FOR H EART FAILURE, HIGH BLOOD PRES SURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTENOUGH BL OOD FLOW TO THE HEART NITR OGLYCERIN SUBLING TAB 0.4MG 4X 25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC U SE: -MEDICATION USED FOR HEA RT FAILURE,HIGH BLOOD PRESSUR E,AND TO TREAT AND PREVENT CH EST PAIN FROM NOT ENOUGH BLOO D FLOW TO THE HEART SOLIFE NACIN SUCCINATE TAB 10MG 90 N DC CODE:68462038790 FDA PRODU CT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA N O.: 209239 INDICATED FOR THE TREATMENT OF OVERACTIVE BLAD DER WITH SYMPTOMS OF URGE URI NARY INCONTINENCE, URGENCY A ND URINARY FREQUENCY NITROG LYCERIN SUBLING TAB 0.3MG 100 NDC CODE:68462063801 FDA PRO DUCT CODE NO.: 66 S C A 28 H . T. S NO.: 3004.90.9020 AND A NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE,A ND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD F LOW TO THE HEART NITROGLYC ERIN SUBLING TAB 0.3MG 100 ND C CODE:68462063801 FDA PRODUC T CODE NO.: 66 S C A 28 H. T . S NO.: 3004.90.9020 ANDA N O.:206391 THERAPEUTIC USE: - MEDICATION USED FOR HEART FAI LURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLOW TO THE HEART NITROGLYCERI N SUBLING TAB 0.3MG 100 NDC C ODE:68462063801 FDA PRODUCT C ODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.: 206391 THERAPEUTIC USE: -MED ICATION USED FOR HEART FAILUR E,HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART COMMERCIAL & CU STOM INVOICE NO. F22687000170 DT. 30.04.2025 F22687000171 DT. 30.04.2025 F22687000191 D T. 30.04.2025 F22687000197 DT . 30.04.2025 F22687000218 DT. 30.04.2025 S/BILL NO: 146830 7 DT:02-MAY-25 S/BILL NO: 146 8288 DT:02-MAY-25 S/BILL NO: 1468290 DT:02-MAY-25 S/BILL N O: 1468308 DT:02-MAY-25 S/BIL L NO: 1468276 DT:02-MAY-25 GROSS WT. 2,306.763 KGS NET W T.202.080 KGS 15 DATA LOGGERS SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUC HATEL - 2000 SWITZERLAND |
| 2025-06-10 |
MAEU253524216 |
GLENMARK PHARMACEUTICALS LTD |
3255.94 kg |
611600
|
19 PACKAGES 731 CARTONS PHAR MACEUTICALS AS UNDER ROSUVA STATIN TAB 5MG 1000 NDC CODE: 68462026110 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 79 172 THERAPEUTICE USE: TO TRE AT HIGH CHOLESTEROL AND RELAT ED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE. R OSUVASTATIN TAB 20MG 1000 NDC CODE:68462026310 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA N O.: 79172 THERAPEUTICE USE: T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO P REVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 20MG 1000 NDC CODE:68462026310 FDA PR ODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 A NDA NO.: 79172 THERAPEUTICE U SE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DI SEASE ROSUVASTATIN TAB 5MG 1000 NDC CODE:68462026110 FD A PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.1 0 ANDA NO.: 79172 THERAPEUTI CE USE: TO TREAT HIGH CHOLEST EROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE. ROSUVASTATIN TAB 20MG 1000 NDC CODE:684620263 10 FDA PRODUCT CODE NO.: 19 PACKAGES 731 CARTONS PHARMAC EUTICALS AS UNDER ROSUVASTA TIN TAB 5MG 1000 NDC CODE:684 62026110 FDA PRODUCT CODE NO. : 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 79172 THERAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CA RDIOVASCULAR DISEASE. ROSU VASTATIN TAB 20MG 1000 NDC CO DE:68462026310 FDA PRODUCT CO DE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 79172 THERAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 20MG 1000 N DC CODE:68462026310 FDA PRODU CT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 79172 THERAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AN D RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEA SE ROSUVASTATIN TAB 5MG 100 0 NDC CODE:68462026110 FDA P RODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 79172 THERAPEUTICE USE: TO TREAT HIGH CHOLESTERO L AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR D ISEASE. ROSUVASTATIN TAB 20 MG 1000 NDC CODE:68462026310 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.0 0.10 ANDA NO.: 79172 THERAPE UTICE USE: TO TREAT HIGH CHOL ESTEROL AND RELATED CONDITION S, AND TO PREVENT CARDIOVASCU LAR DISEASE COMMERCIAL & C USTOM INVOICE NO. F2265200057 3 DT. 30.04.2025 F22652000522 DT. 30.04.2025 F22652000554 DT. 30.04.2025 F22652000571 D T. 30.04.2025 F22652000579 DT . 30.04.2025 S/BILL NO: 14806 92 DT 02-MAY-2025 S/BILL NO: 1480690 DT 02-MAY-2025 S/BILL NO: 1480703 DT 02-MAY-2025 S /BILL NO: 1480700 DT 02-MAY-20 25 S/BILL NO: 1480704 DT 02-M AY-2025 GROSS WT. 3,256.020 K GS NET WT.2879.046 KGS 19 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY :2 GLENMARK SPECIALTY S.A. S WITZERLAND (GSSA) PLACE DU PO RT 2 NEUCHATEL - 2000 SWITZE RLAND |
| 2025-06-10 |
MAEU253708223 |
GLENMARK PHARMACEUTICALS LTD |
6689.69 kg |
300490
|
26 PACKAGES 2354 CARTONS PHA RMACEUTICALS AS UNDER RANOL AZINE ER TAB 1000MG 60 NDC CO DE:68462032060 FDA PRODUCT CO DE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO.: 211082 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDICATIO N. IT WORKS BY IMPROVING BLOO D FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CH EST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) A TTACK OF ANGINA PROCHLORPE RAZINE MAL TAB 5MG 100 NDC CO DE:68462088901 INDOMETHACIN ER CAP 75MG 60 NDC CODE:6846 2032560 FDA PRODUCT CODE: 62 GCE42 H. T. S NO.:3004.90.9 2.40 ANDA NO.203501 THERAPEU TIC USE: INDOMETHACIN IS USED TO RELIEVE PAIN, SWELLING, AND JOINT STIFFNESS CAUSED BY ARTHRITIS, GOUT, BURSITIS, A ND TENDONITIS. IT IS ALSO USE D TO RELIEVE PAIN FROM VARIOU S OTHER CONDITIONS. THIS MED ICATION IS KNOWN AS A NONSTER OIDAL ANTI-INFLAMMATORY DRUG (NSAID). ... THIS EFFECT HEL PS TO DECREASE SWELLING AND PAIN. FENOFIBRATE CAP 67MG 100 NDC CODE:68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTI VE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDES AND APO B IN D ULT PATIENTS WITH PRMARY HY PERCHOLESTEROLEMIA OR MIXED D YSLIPIDEMIA CARVEDILOL TAB 12.5MG 500 NDC CODE:684620164 05 FDA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANT AGONIST CARVEDILOL TAB 12.5 MG 500 NDC CODE:68462016405 FDA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE: -BETA- ADRENOACEPTOR ANTAGON IST COMMERCIAL & CUSTOM INV OICE NO. F22687000164 DT. 30. 04.2025 F22687000182 DT. 30.0 4.2025 S/BILL NO: 1468287 DT: 02-MAY-25 S/BILL NO: 1468278 DT:02-MAY-25 GROSS WT. 6,689. 904 KGS NET WT.4116.775 KGS 02 DATA LOGGERS SET TEMPE RATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA |
| 2025-06-10 |
MAEU253525462 |
GLENMARK PHARMACEUTICALS LTD |
5129.31 kg |
611600
|
20 PACKAGES 2591 CARTONS PHA RMACEUTICALS AS UNDER ROSUV ASTATIN TAB 5MG 90 NDC CODE:6 8462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 0791 72 THERAPEUTICE USE: - TO TR EAT HIGH CHOLESTEROL AND RELA TED CONDITIONS, AND TO PREVEN T CARDIOVASCULAR DISEASE R OSUVASTATIN TAB 20MG 90 NDC C ODE:68462026390 FDA PRODUCT C ODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO P REVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 5MG 1000 NDC CODE:68462026110 FDA PRO DUCT CODE NO.: 61 J C A 16 H . T. S NO.: 3004.49.00.10 AN DA NO.: 79172 THERAPEUTICE US E: TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DIS EASE. ROSUVASTATIN TAB 20MG 90 NDC CODE:68462026390 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTIC E USE: - TO TREAT HIGH CHOLES TEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCUL AR DISEASE COMMERCIAL & CUS TOM INVOICE NO. F22652000505 DT. 30.04.2025 F22652000507 D T. 30.04.2025 F22652000469 DT . 29.04.2025 S/BILL NO: 15092 92 DT 03-MAY-2025 S/BILL NO: 1509537 DT 03-MAY-2025 S/BILL NO: 1515129 DT 04-MAY-2025 GROSS WT. 5,129.510 KGS NET WT.3970.41 KGS 20 DATA LOGGE RS SET TEMPERATURE : +18 DE GREES NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. SWITZERLAN D (GSSA) PLACE DU PORT 2 NEU CHATEL - 2000 SWITZERLAND |
| 2025-05-20 |
MAEU252321805 |
GLENMARK PHARMACEUTICALS LTD |
12120.19 kg |
300490
|
48 PACKAGES 3342 CARTONS PHA RMACEUTICALS AS UNDER DICLO FENAC SOD GEL 3% 100GM NDC CO DE:68462035594 FDA PRODUCT CO DE NO.:62 G C J 18 H. T. S N O.: 3004.90.92.40 ANDA NO.:2 08301 THERAPEUTICE USE: - US ED FOR THE RELIEF OF JOINT PA IN OF OSTEOARTHRITIS |
| 2025-05-20 |
MAEU252321810 |
GLENMARK PHARMACEUTICALS LTD |
12257.18 kg |
300490
|
48 PACKAGES 2067 CARTONS PHA RMACEUTICALS AS UNDER PRAMI PEXOLE TAB 1.5MG 90 NDC CODE: 68462033490 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO. : 3004.90.92.40 ANDA NO.: 90 -781 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE PRAM IPEXOLE TAB 1.5MG 90 NDC |
| 2025-05-20 |
MAEU252321808 |
GLENMARK PHARMACEUTICALS LTD |
10257.26 kg |
300490
|
48 PACKAGES 3329 CARTONS PHA RMACEUTICALS AS UNDER ATOMO XETINE CAP 40MG 30 NDC CODE:6 8462026830 FDA PRODUCT CODE N O.: 64 UCA 99 H. T. S NO.: 3004.90.92.90 ANDA NO.: 07901 9 THERAPEUTICE USE: - ATOMOX ETINE IS USED TO TREAT ATTENT ION-DEFICIT HYPERACTIV |
| 2025-05-20 |
MAEU252724769 |
GLENMARK PHARMACEUTICALS LTD |
5371.53 kg |
612600
|
32 PACKAGES 2520 CARTONS PHA RMACEUTICALS AS UNDER ONDAN SETRON ODT 4MG 30UD NDC CODE: 68462015713 FDA PRODUCT CODE NO,:-61 T C A 26 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -152 THERAPEUTICE USE:-ANTI -EMETIC ATOMOXETINE CAP 40M G 30 NDC CODE:68462026830 |
| 2025-05-20 |
MAEU252517953 |
GLENMARK PHARMACEUTICALS LTD |
9066.56 kg |
300490
|
40 PACKAGES 1353 CARTONS PHA RMACEUTICALS AS UNDER OMEPR AZOLE DR CAP 40MG 1000 NDC CO DE:68462039710 FDA PRODUCT CO DE NO.:62KCF10 HTS NO.3004.9 0.9255 ANDA NO.:91672 THERAP EUTICE USE: -TREATMENT OF TRE AT GASTROESOPHAGEAL REFLUX D ISEASE GABAPENTIN TAB |
| 2025-04-29 |
MAEU251247795 |
GLENMARK PHARMACEUTICALS LTD |
8276.84 kg |
300490
|
40 PACKAGES 922 CARTONS PHAR MACEUTICALS AS UNDER OMEPRA ZOLE DR CAP 40MG 1000 NDC COD E:68462039710 FDA PRODUCT COD E NO.:62KCF10 HTS NO.3004.90 .9255 ANDA NO.:91672 THERAPE UTICE USE: -TREATMENT OF TREA T GASTROESOPHAGEAL REFLUX DI SEASE CICLOPIROX OLAM |
| 2025-04-29 |
MAEU251685069 |
GLENMARK PHARMACEUTICALS LTD |
5606.5 kg |
652400
|
40 PACKAGES 1997 CARTONS PHA RMACEUTICALS AS UNDER HEATH ER TAB 0.35MG 84 NDC CODE:684 62030329 FDA PRODUCT CODE NO. : 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.:90-454 THERAPEUTICE USE: PREVENTIO N OF PREGNANCY. DROSPIRENON E/EE TAB 3/0.02MG 84 NDC |
| 2025-04-29 |
MAEU251729629 |
GLENMARK PHARMACEUTICALS LTD |
1633.41 kg |
611600
|
8 PACKAGES 487 CARTONS PHARM ACEUTICALS AS UNDER ROSUVAS TATIN TAB 20MG 90 NDC CODE:68 462026390 FDA PRODUCT CODE N O.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 07917 2 THERAPEUTICE USE: - TO TRE AT HIGH CHOLESTEROL AND RELAT ED CONDITIONS, AND TO |
| 2025-04-29 |
MAEU251801838 |
GLENMARK PHARMACEUTICALS LTD |
839.16 kg |
662800
|
4 PACKAGES 123 CARTONS PHARM ACEUTICALS AS UNDER NITROGL YCERIN SUBLING TAB 0.4MG 100 NDC CODE:68462063901 FDA PROD UCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.: 206391 THERAPEUTICE USE : -MEDICATION USED FOR HEART FAILURE, HIGH BLOOD PRES |
| 2025-04-29 |
MAEU251577773 |
GLENMARK PHARMACEUTICALS LTD |
8092.22 kg |
621700
|
43 PACKAGES 3234 CARTONS PHA RMACEUTICALS AS UNDER ROPIN IROLE TAB 4MG 100 NDC CODE:68 462025801 FDA PRODUCT CODE N O.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90- 135 THERAPEUTICE USE:-TREATM ENT OF PARKINSONISM OLMESA RTAN MEDOX TAB 20MG 90 ND |
| 2025-04-29 |
MAEU251577968 |
GLENMARK PHARMACEUTICALS LTD |
6119.52 kg |
652700
|
40 PACKAGES 1973 CARTONS PHA RMACEUTICALS AS UNDER NORGE ST/EE TAB 0.25/0.035MG 84 NDC CODE:68462030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA N O.: 200538 THERAPEUTICE USE: - ORAL CONTRACEPTIVES NORE TH ACE/EE TAB 0.5MG/2.5MCG |
| 2025-04-29 |
MAEU251247620 |
GLENMARK PHARMACEUTICALS LTD |
6198.44 kg |
642800
|
40 PACKAGES 2356CARTONS PHAR MACEUTICALS AS UNDER NORETH ACE/EE TAB 1MG/5MCG 90 NDC C ODE:68462065790 FDA PRODUCT C ODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO. : 203038 THERAPEUTICE USE: - TREATMENT OF MODERATE TO SEV ERE VASOMOTOR SYMPTOMS D |
| 2025-04-29 |
MAEU251577967 |
GLENMARK PHARMACEUTICALS LTD |
8079.98 kg |
300490
|
37 PACKAGES 1721CARTONS PHAR MACEUTICALS AS UNDER TOPIRA MATE ER CAP (Q) 150MG 30 NDC CODE:68462037030 3004.49.00.2 0 61 M C B 40 210278 TOPI RAMATE ER CAP (Q) 50MG 30 NDC CODE:68462037330 3004.49.00. 20 61 M C B 40 210278 TOP IRAMATE ER CAP (Q) 100MG 30 |
| 2025-04-29 |
MAEU251247790 |
GLENMARK PHARMACEUTICALS LTD |
343.38 kg |
611600
|
2 PACKAGES 60 CARTONS PHARMA CEUTICALS AS UNDER ROSUVAST ATIN TAB 20MG 1000 NDC CODE:6 8462026310 FDA PRODUCT CODE N O.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 791 72 THERAPEUTICE USE: TO TREA T HIGH CHOLESTEROL AND RELATE D CONDITIONS, AND TO P |
| 2025-04-22 |
MAEU251247785 |
GLENMARK PHARMACEUTICALS LTD |
10215.53 kg |
300490
|
44 PACKAGES 2659 CARTONS PHA RMACEUTICALS AS UNDER TELMI SARTAN TAB 40MG 30 NDC CODE:6 8462020030 FDA PRODUCT CODE N O.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO.:0900 32 THERAPEUTICE USE: INDICAT ED FOR THE TREATMENT OF HYPE RTENSION, TO LOWER BLOO |
| 2025-04-22 |
MAEU251247788 |
GLENMARK PHARMACEUTICALS LTD |
9855.82 kg |
300490
|
45 PACKAGES 1962 CARTONS PHA RMACEUTICALS AS UNDER OMEPR AZOLE DR CAP 40MG 1000 NDC CO DE:68462039710 FDA PRODUCT CO DE NO.:62KCF10 HTS NO.3004.9 0.9255 ANDA NO.:91672 THERAP EUTICE USE: -TREATMENT OF TRE AT GASTROESOPHAGEAL REFLUX D ISEASE INDOMETHACIN C |
| 2025-04-22 |
MAEU251247793 |
GLENMARK PHARMACEUTICALS LTD |
9799.12 kg |
300490
|
46 PACKAGES 2361 CARTONS PHA RMACEUTICALS AS UNDER TELMI SARTAN TAB 40MG 90 NDC CODE:6 8462020090 FDA PRODUCT CODE N O :62 O C A 09 HTS NO : 3004 .90.92.20 ANDA NO.90032 THER APEUTICE USE:-INDICATED FOR T HE TREATMENT OF HYPERTENSION , TO LOWER BLOOD PRES |